Skip to content

Enfusion, Inc.

Delisted

CIK 1868912fmd_04D1QM6R5350ZGRVQVNKZYY6C0Services · Services-Prepackaged SoftwareTemplate: Standard

Coverage: Jan 01, 2019 to Dec 31, 2024, 18 periods

Latest annual · FY2024

Millions
Total revenues
202
Gross profit
137
Operating income
6
Net income
3
Free cash flow
31

Latest quarter · Q4 FY2024

Millions
Total revenues
53
Gross profit
37
Operating income
2
Net income
0
Free cash flow
9
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2021 to FY2024
+21.8%
Revenue, 5 yearsFY2019 to FY2024
+27.8%
Net income, 5 yearsFY2019 to FY2024
-25.9%

Enfusion, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2024FY2023ChangeSource
Revenue$201.6 million$174.5 million+15.5%10-K 2025-03-03 · proof
Gross profit$136.7 million$116.9 million+17%10-K 2025-03-03 · proof
Operating income$6.2 million$11.9 million-48.5%10-K 2025-03-03 · proof
Net income$2.8 million$6 million-53.1%10-K 2025-03-03 · proof
Cash from operating activities$34.7 million$25.6 million+35.3%10-K 2025-03-03 · proof
Free cash flow$31 million$21.2 million+46.6%10-K 2025-03-03 · proof
Total assets$143.3 million$109 million+31.5%10-K 2025-03-03 · proof
Total liabilities$43.7 million$31.5 million+38.8%10-K 2025-03-03 · proof
Cash and cash equivalents$54.5 million$35.6 million+53%10-K 2025-03-03 · proof
What was Enfusion, Inc.'s revenue in fiscal 2024?
Enfusion, Inc. reported revenue of $201.6 million for fiscal 2024 (the year ended Dec 31, 2024), against $174.5 million the year before (+15.5%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What was Enfusion, Inc.'s gross profit in fiscal 2024?
Enfusion, Inc. reported gross profit of $136.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $116.9 million the year before (+17%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What was Enfusion, Inc.'s operating income in fiscal 2024?
Enfusion, Inc. reported operating income of $6.2 million for fiscal 2024 (the year ended Dec 31, 2024), against $11.9 million the year before (-48.5%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What was Enfusion, Inc.'s net income in fiscal 2024?
Enfusion, Inc. reported net income of $2.8 million for fiscal 2024 (the year ended Dec 31, 2024), against $6 million the year before (-53.1%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What was Enfusion, Inc.'s cash from operating activities in fiscal 2024?
Enfusion, Inc. reported cash from operating activities of $34.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $25.6 million the year before (+35.3%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What was Enfusion, Inc.'s free cash flow in fiscal 2024?
Enfusion, Inc. reported free cash flow of $31 million for fiscal 2024 (the year ended Dec 31, 2024), against $21.2 million the year before (+46.6%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What are Enfusion, Inc.'s total assets?
As of Dec 31, 2024, Enfusion, Inc. reported total assets of $143.3 million, against $109 million a year earlier (+31.5%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What are Enfusion, Inc.'s total liabilities?
As of Dec 31, 2024, Enfusion, Inc. reported total liabilities of $43.7 million, against $31.5 million a year earlier (+38.8%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC
What are Enfusion, Inc.'s cash and cash equivalents?
As of Dec 31, 2024, Enfusion, Inc. reported cash and cash equivalents of $54.5 million, against $35.6 million a year earlier (+53%). Source: the 10-K filed with the SEC on Mar 3, 2025. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1868912&period_type=annual&limit=5"

Information only, not investment advice.